본문 바로가기
KERD
논문KCI 등재

Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers

Faisal Mousa Alzahrani|Muzaheed|Saeed Sattar Shaikh,|Amer Ibrahim Alomar,|Sadananda Acharya,|Nasreldin Elhadi,
대한진단검사의학회 (Korean Society For Laboratory Medicine)|2019.01|Annals of Laboratory Medicine|제39권 제1호|pp. 81-85|DOI 10.3343/alm.2019.39.1.81

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

PrevalenceSaudi ArabiaBlood donorsHepatitis B virusHepatitis B virus surface antigenAntibody against hepatitis B virus core antigenNucleic acid test
주제분류병리학

초록

Background: Transfusion-transmissible hepatitis B virus (HBV) infection is a major problem worldwide. Recently, confirmatory nucleic acid tests (NATs) for HBV DNA have been employed in several countries. We assessed the prevalence and yearly trends of HBV infection in blood donors in the Eastern Province of Saudi Arabia, screening for HBV surface antigen (HBsAg), antibody against HBV core antigen (anti-HBc), and HBV DNA. Methods: Between 2011 and 2015, a total of 22,842 donors were screenedfor HBsAg, anti-HBc, and HBV DNA using the HBsAg Qualitative II kit (Abbott, Ireland Diagnostics Division, Sligo, Ireland), ARCHITECT Anti-hepatitis B core antigen antibody (HBc) II Assay kit (Abbott GmbH & Co. KG, Wiesbaden, Germany), and NAT Procleix Ultrio Elite Assay kit (Grifols Diagnostic Solutions Inc., Los Angeles, CA, USA), respectively. Results: A total of 739 (3.24%) donors were HbsAg(+), anti-HBc(+), or HBV DNA(+); 63 (0.28%) were HbsAg(+), anti-HBc(+), and HBV DNA(+). Twelve (0.05%) were anti-HBc(+) and HBV DNA(+) but HBsAg(-); they were considered to have occult infection. Further, 664 (2.91%) were HBsAg(-) but anti-HBc(+), indicating chronic or resolving infection. HBV prevalence increased significantly from 2011 to 2012, increased marginally till 2013, and showed a decreasing trend from 2013 (P>0.05). Conclusions: The five-year prevalence of HBV infection among blood donors in the Eastern Province of Saudi Arabia (3.24%) is lower than that reported for other regions in the country. The occult HBV infection rate of 0.05% emphasizes the importance of NATs in isolating potential infectious blood units.

Abstract

Background: Transfusion-transmissible hepatitis B virus (HBV) infection is a major problem worldwide. Recently, confirmatory nucleic acid tests (NATs) for HBV DNA have been employed in several countries. We assessed the prevalence and yearly trends of HBV infection in blood donors in the Eastern Province of Saudi Arabia, screening for HBV surface antigen (HBsAg), antibody against HBV core antigen (anti-HBc), and HBV DNA. Methods: Between 2011 and 2015, a total of 22,842 donors were screenedfor HBsAg, anti-HBc, and HBV DNA using the HBsAg Qualitative II kit (Abbott, Ireland Diagnostics Division, Sligo, Ireland), ARCHITECT Anti-hepatitis B core antigen antibody (HBc) II Assay kit (Abbott GmbH & Co. KG, Wiesbaden, Germany), and NAT Procleix Ultrio Elite Assay kit (Grifols Diagnostic Solutions Inc., Los Angeles, CA, USA), respectively. Results: A total of 739 (3.24%) donors were HbsAg(+), anti-HBc(+), or HBV DNA(+); 63 (0.28%) were HbsAg(+), anti-HBc(+), and HBV DNA(+). Twelve (0.05%) were anti-HBc(+) and HBV DNA(+) but HBsAg(-); they were considered to have occult infection. Further, 664 (2.91%) were HBsAg(-) but anti-HBc(+), indicating chronic or resolving infection. HBV prevalence increased significantly from 2011 to 2012, increased marginally till 2013, and showed a decreasing trend from 2013 (P>0.05). Conclusions: The five-year prevalence of HBV infection among blood donors in the Eastern Province of Saudi Arabia (3.24%) is lower than that reported for other regions in the country. The occult HBV infection rate of 0.05% emphasizes the importance of NATs in isolating potential infectious blood units.

참고문헌 (34)

  1. "Fact sheets, hepatitis B Key Facts" (2018)[URL]
  2. "World Hepatitis Day report" (2018)[URL]
  3. Lok AS, "Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B", Hepatology, 34, pp.1225~1241 (2001)
  4. Song Y, "Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010", Plos One, 9, pp.e94528~ (2014)
  5. Japhet MO, "Hepatitis B core IgM antibody(anti-HBcIgM)among hepatitis B surface antigen(HBsAg)negative blood donors in Nigeria", Virol J, 8, pp.513~ (2011)
  6. Schmidt M, "Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq", BMJ Open Gastroenterol, 3, pp.e000067~ (2016)
  7. Shobokshi OA, "Hepatitis B surface gene mutants and their emerging role in the efficacy of HBV vaccination programs", Ann Saudi Med, 19, pp.87~92 (1999)
  8. Bashawri LA, "Prevalence of seromarkers of HBV and HCV among blood donors in Eastern Saudi Arabia, 1998-2001", Clin Lab Haematol, 26, pp.225~228 (2004)
  9. El-Hazmi MM, "Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I", II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia, 2004, pp.2, 26~33
  10. El Beltagy KE, "Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, Northwestern Saudi Arabia", Int J Infect Dis, 12, pp.495~499 (2008)
  11. Xiao X, "Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System", J Virol Methods, 187, pp.357~361 (2013)
  12. Allain JP, "Occult hepatitis B virus infection : implications in transfusion", Vox Sang, 86, pp.83~91 (2004)
  13. El-Zayadi AR, "Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission", Transfus Med, 18, pp.55~61 (2008)
  14. Weber B, "Hepatitis B virus markers in anti-HBc only positive individuals", J Med Virol, 64, pp.312~319 (2001)
  15. Kurdi M, "Molecular detection of hepatitis B virus(HBV)among voluntary ELISA positive blood donors in Almadinah Almunawwarah", J Taibah Univ Med Sci, 9, pp.166~170 (2014)
  16. El Beltagy KE, "Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, Northwestern Saudi Arabia", Int J Infect Dis, 12, pp.495~499 (2008)
  17. Mohammed Abdullah S, "Prevalence of hepatitis B and C in donated blood from the Jazan region of Saudi Arabia", Malays J Med Sci, 20, pp.41~46 (2013)
  18. Mahaba HM, "Pattern of HBsAg positivity in selected groups at King Khalid General Hospital-Hail region, Kingdom of Saudi Arabia", J Fam Commun Med, 4, pp.30~36 (1997)
  19. Mahoney FJ, "Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection", J Infect Dis, 167, pp.203~207 (1993)
  20. Ramia S, "Frequency and significance of antibodies against hepatitis B core(anti-HBc)antigen as the only serological marker for hepatitis B infection in Lebanese blood donors", Epidemiol Infect, 133, pp.695~699 (2005)
  21. Kaminski G, "Evidence of occult hepatitis B virus infection among Omani blood donors : a preliminary study", Med Princ Pract, 15, pp.368~372 (2006)
  22. Behzad-Behbahani A, "Anti-HBc and HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection", Indian J Med Res, 123, pp.37~42 (2006)
  23. Karimi G, "Prevalence of antibody to hepatitis B core antigen and hepatitis B virus DNA in HBsAg negative healthy blood donors", Virol J, 13, pp.36~ (2016)
  24. Badrawy H, "Anti-HBc and HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen", Am J Mol Biol, 3, pp.62~66 (2013)
  25. Zekri AR, "Evaluation of blood units with isolated anti HBC for the presence of HBV DNA", Dis Markers, 18, pp.107~110 (2002)
  26. Bodhiphala P, "Detection of HBV genome by gene amplification method in HBsAg negative blood donors", J Med Assoc Thai, 82, pp.491~495 (1999)
  27. Findik D, "Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg and anti-HBs-negative serology and antibodies to hepatitis B core antigen", Eur J Intern Med, 18, pp.571~575 (2007)
  28. Arabaci F, "Investigation of mutant hepatitis B virus in core antibody seropositive cases of blood donor population", J Med Sci, 8, pp.316~320 (2008)
  29. Zervou EK, "Value of anti-HBc screening of blood donors for prevention of HBV infection : results of a 3-year prospective study in Northwestern Greece", Transfusion, 41, pp.652~658 (2001)
  30. Schmidt M, "Anti-HBc screening of blood donors : a comparison of nine anti-HBc tests", Vox Sang, 91, pp.237~243 (2006)
  31. Asim M, "Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection : implications for blood transfusion", Indian J Med Res, 132, pp.312~317 (2010)
  32. Said ZN, "Occult hepatitis B virus infection among Egyptian blood donors", World J Hepatol, 5, pp.64~73 (2013)
  33. Mahmoud OA, "Detection of occult hepatitis B virus infection among blood donors in Sudan", J Egypt Public Health Assoc, 88, pp.14~18 (2013)
  34. Aljarbou AN, "The emergent concern of hepatitis B globally with special attention to Kingdom of Saudi Arabia", Int J Health Sci, 7, pp.333~340 (2013)

관련 논문AI추천

Pre- and Post-transfusion Testing for Hepatitis B Virus Surface Antigen and Antibody in Blood Recipients: A Single-Institution Experience in an Area of High Endemicity김형수, 문희원, 박경식, 박철민, 이건세, 장성훈, 조진희, 허미나대한진단검사의학회 · Annals of Laboratory Medicine2012 · 제32권 제1호Occult HBV among Anti-HBc Alone: Mutation Analysis of an HBV Surface Gene and Pre-S Gene강소영, 김명희, 이우인연세대학교의과대학 · Yonsei Medical Journal2017 · 제58권 제3호Inactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year studyNese Demirturk, Tuna Demirdal대한간학회 · Clinical and Molecular Hepatology2014 · 제20권 제1호Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic HepatitisBi-sheng Shi,, Dan Huang,, Dan-ping Liu,, Rong-rong Ding,, Wei Lu,, Xiao-nan Zhang,, Xin-lan Zhou,, Xiu-fen Li,, Yan-bing Wang,, Zhan-qing Zhang대한진단검사의학회 · Annals of Laboratory Medicine2019 · 제39권 제1호Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California ValleyAdnan Ameer, Humaira Sadiq, Muhammad Y. Sheikh, Patrick C. Sadler, Pradeep R. Atla거트앤리버 소화기연관학회협의회 · Gut and Liver2013 · 제7권 제1호Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay김원, 김병관, 김지원, 김휘영, 서지연, 이국래, 이호영, 정광현, 정용진, 정지봉, 조유리, 진은효거트앤리버 소화기연관학회협의회 · Gut and Liver2015 · 제9권 제5호

이 간행물의 다른 논문 (18건)

Advances in Automated Urinalysis Systems, Flow Cytometry and Digitized Microscopy조선영, 허미나pp. 1-2Laboratory Testing in Thyroid Conditions – Pitfalls and Clinical UtilityTar-Choon Aw, Shui-Boon Sohpp. 3-14Progress in Automated UrinalysisJoris Delanghe, Matthijs Oyaert, M.Sc.,pp. 15-22Effectiveness of Platelet Function Analyzer-100 for Laboratory Detection of Anti-Platelet Drug-Induced Platelet Dysfunction김혜련, 이미경, 김보현, 임용관, 권오주pp. 23-30Evaluation of the SD Bioline Strep A Ultra Test in Relation With Number of Colony Forming Units and Color Intensity마상혁, 김선주, 최원희, 박현웅pp. 31-35
원문 보기